A Republican bill with 2 Democratic cosponsors · See all 3 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The MIRACLE Medical Technology Act of 2025 requires the Secretary of Health and Human Services to lead a program coordinating health care collaboration between the United States and Israel. This program focuses on the development and delivery of health care products and services. It includes joint research, support for start-ups, and regulatory alignment. The bill also emphasizes biological product manufacturing and digital health cooperation. A joint Health Care Collaboration Center may be established in the United States. The program is authorized for $8,000,000 annually from 2026 through 2030.
Yes· 3 of 39
- Scored +7
Does this strengthen ties with allied countries?
Strengthens diplomatic and scientific ties between the US and Israel.
- Scored +6
Would business owners be better off under this?
Strong support for start-ups and joint venture opportunities.
- Scored +6
Does this favour talking over confrontation abroad?
Coordinates high-level collaboration between health and commerce secretaries and foreign counterparts.
The opposite· 3 of 4
- Scored -2
Does this give people more control over their personal data?
Creates frameworks for sharing health data, raising potential privacy concerns.
- Scored -2
Does this protect people from being watched or searched?
Facilitates the sharing of health data across international borders.
- Scored -1
Does this reduce what the federal government owes?
Requires new federal spending of $8 million annually through 2030.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Medical Products: The bill promotes collaboration on medical device technology, pharmaceuticals, and biological products, which can lead to better health care solutions (Section 2(b)(1)(B)).
-
Lower Costs and Higher Quality: By supporting advanced manufacturing techniques for biological products, the bill aims to reduce costs, improve product quality, and increase productivity (Section 2(b)(1)(C)).
-
Faster Access to Treatments: The bill pursues the accelerated development of life-saving treatments and affordable, healthier nutrition sources (Section 2(b)(7)(C)).
-
Stronger Supply Chains: Strategic collaboration to create contingency plans helps prevent disruptions in the supply of biological products (Section 2(b)(7)(E)).
-
Disease Prevention: Joint efforts to develop vaccines, combat infectious diseases, and share epidemiological data can improve public health (Section 2(b)(6)).
-
Job Training: The bill promotes exchange programs and training to develop a skilled workforce in biological product manufacturing (Section 2(b)(7)(D)).
Potential Negative Impacts for People
-
Data Privacy Concerns: The bill seeks to develop a framework for sharing health data with the Ministry of Health of Israel (Section 2(b)(1)(D)) and promotes interoperability between the two countries' health care systems (Section 2(b)(5)(B)).
-
Financial Cost: The program requires the appropriation of $8,000,000 for each fiscal year from 2026 through 2030 (Section 2(e)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would business owners be better off under this? — Strong support for start-ups and joint venture opportunities. Would people with disabilities be better off under this? — Focus on medical device technology and life-saving treatments. Would households on low incomes be better off under this? — Aims to reduce costs of biological products and provide affordable nutrition. Would retired people be better off under this? — Potential for lower costs and better quality of biological treatments. Would people in rural areas be better off under this? — Focus on telemedicine infrastructure and digital health. Would people over 65 be better off under this? — Potential for better oncology products and life-saving medical devices. Would students be better off under this? — Exchange programs and skill development for future workforce. Would Black Americans be better off under this? — Broad improvement in health care product availability and costs. Would Asian Americans be better off under this? — Broad improvement in health care product availability and costs. Would billionaires be better off under this? — Market expansion for health care technology companies. Would children be better off under this? — Potential for new life-saving treatments and healthier nutrition sources. Would high-income households be better off under this? — Increased access to cutting-edge health technologies. Would people with substantial wealth be better off under this? — Investment opportunities in the emerging med-tech sector. Would Hispanic Americans be better off under this? — Broad improvement in health care product availability and costs. Would LGBTQ people be better off under this? — General medical advancement benefit. Would men be better off under this? — General medical advancement benefit. Would people in middle age be better off under this? — Improved access to advanced medical technologies. Would middle-income households be better off under this? — Increased access to quality medical innovations. Would Native Americans be better off under this? — Broad improvement in health care product availability and costs. Would the very wealthiest people be better off under this? — Investment opportunities in high-growth biotech. Would people in cities be better off under this? — Better access to high-tech medical centers. Would veterans be better off under this, taking everything together? — Potential access to improved medical technologies. Would white Americans be better off under this? — Broad improvement in health care product availability and costs. Would women be better off under this? — General medical advancement benefit. Would people in their twenties and thirties be better off under this? — Opportunity for workforce training and exchange programs in biotech.
- National Security And Foreign Policy
- Does this strengthen ties with allied countries? — Strengthens diplomatic and scientific ties between the US and Israel. Does this favour talking over confrontation abroad? — Coordinates high-level collaboration between health and commerce secretaries and foreign counterparts. Does this make trade with other countries easier? — Facilitates technology transfer and commercialization in the Israeli market. Does this better protect the country from computer attacks? — Promotes cybersecurity standards for sharing health data.
- Healthcare
- Does this make the country readier for the next outbreak? — Collaborates on vaccine development and combating infectious diseases. Does this make health care easier to get in general? — Promotes the development and delivery of life-saving treatments and digital health solutions. Does this put more money into medical research? — Establishes joint research projects and a Health Care Collaboration Center. Does this lower the price of prescription medicines? — Aims to reduce costs through advanced manufacturing of biological products.
- Economy And Finance
- Does this make it easier to run a small business? — Specifically fosters collaboration for start-ups in the health care sector. Is this likely to grow the economy? — Fosters innovation and commercialization of health care technologies. Is this likely to create jobs? — Promotes start-up ecosystems and workforce training in biological product manufacturing. Does this reduce what the federal government spends? — Increases government spending for the collaboration program. Does this reduce what the federal government owes? — Requires new federal spending of $8 million annually through 2030.
- Education And Technology
- Does this put more money into scientific research? — Directly funds and coordinates joint medical research projects. Does this make patent and copyright rules fairer? — Establishes joint efforts to ensure intellectual property protection. Does this give people more control over their personal data? — Creates frameworks for sharing health data, raising potential privacy concerns.
- Governance And Ideology
- Does this give the federal government more power? — Assigns new coordinating responsibilities to the HHS Secretary. Does this protect people from being watched or searched? — Facilitates the sharing of health data across international borders.
- 12/23/2025
- 1 Cosponsor added.
- 1/23/2025
- Referred to the House Committee on Energy and Commerce.
- 2 Cosponsors added.
- Introduced in House
Mariannette Miller-MeeksRepublican · Iowa
Darren SotoDemocrat · Florida
Thomas SuozziDemocrat · New York